Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University of Utah
Sponsor:
Collaborators:
Myeloproliferative Disorders-Research Consortium
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Utah
ClinicalTrials.gov Identifier:
NCT00715247
First received: July 11, 2008
Last updated: October 5, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2020
  Estimated Primary Completion Date: July 2020 (Final data collection date for primary outcome measure)